Zonisamide in Advanced Parkinson's Disease: A Randomized Placebo-controlled Study in Egyptian Population

被引：0
|
作者：
Salim, M.
Shalash, S.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
114
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 50 条
  • [21] Mucuna pruriens in parkinson's disease: a double-blind, randomized, placebo-controlled, crossover study
    Cilia, R.
    Laguna, J.
    Cassani, E.
    Cereda, E.
    Pezzoli, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E262 - E263
  • [22] Helicobacter pylori eradication in Parkinson's disease: A double-blind randomized placebo-controlled study
    Tan, A. H.
    Lim, S. Y.
    Mahadeva, S.
    Loke, M. F.
    Vadivelu, J. S.
    Marras, C.
    Fox, H.
    Lang, A. E.
    MOVEMENT DISORDERS, 2020, 35 : S422 - S425
  • [23] Atomoxetine for the Treatment of Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
    Weintraub, Daniel
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A67 - A67
  • [24] Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease
    Putt, ME
    Ravina, B
    CONTROLLED CLINICAL TRIALS, 2002, 23 (02): : 111 - 126
  • [25] A randomized, double-blind, placebo-controlled study of atornoxetine for freezing of gait in Parkinson's disease
    Nashatizadeh, M. M.
    Jimenez, J. E.
    Davidson, A. L.
    Jankovic, J.
    MOVEMENT DISORDERS, 2008, 23 (01) : S219 - S219
  • [26] Atomoxetine for the treatment of depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Weintraub, D.
    Mavandadi, S.
    Horn, S.
    Hurtig, H.
    Siderowf, A.
    Duda, J.
    Stern, M.
    MOVEMENT DISORDERS, 2009, 24 : S286 - S286
  • [27] Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
    Zhang, Zhen-Xin
    Liu, Chun-Feng
    Tao, En-Xiang
    Shao, Ming
    Liu, Yi-Ming
    Wang, Jian
    Asgharnejad, Mahnaz
    Xue, Hai-Bo
    Surmann, Erwin
    Bauer, Lars
    PARKINSONISM & RELATED DISORDERS, 2017, 44 : 6 - 12
  • [28] Rapid efficacy of a noradrenergic reuptake inhibitor in depression in advanced Parkinson's disease:: A double-blind, randomized, placebo-controlled study
    Devos, D.
    Poirot, I.
    Dujardin, K.
    Duhem, S.
    Lucas, B.
    Waucquier, N.
    Moreau, C.
    Bocquillon, P.
    Devos, P.
    Ajebbar, K.
    Thielemans, B.
    Cottencin, O.
    Thomas, P.
    Destee, A.
    Bordet, R.
    Defebvre, L.
    MOVEMENT DISORDERS, 2007, 22 : S223 - S224
  • [29] A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease
    Marrinan, Sarah L.
    Otiker, Tal
    Vasist, Lakshmi S.
    Gibson, Rachel A.
    Sarai, Bhopinder K.
    Barton, Matthew E.
    Richards, Duncan B.
    Hellstrom, Per M.
    Nyholm, Dag
    Dukes, George E.
    Burn, David J.
    MOVEMENT DISORDERS, 2018, 33 (02) : 329 - 332
  • [30] A placebo-controlled study of memantine in advanced Alzheimer's disease.
    Reisberg, B
    Stoeffler, A
    Ferris, S
    Schmitt, F
    Doody, R
    Moebuis, HJ
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (02): : 90 - 90
12345